$AMRN - On our trading list. Roth Capital says buy the dip in Amarin shares after a generic company gets FDA approval for a generic version of Vascepa.Roth Capital says buy Amarin as at-risk generic launch unlikelyWhile Amarin (AMRN) is trading lower after Hikma Pharmaceuticals (HKMPF) announced the first FDA approval for a generic Vascepa, there is a low likelihood of an at-risk launch, Roth Capital analyst Yasmeen Rahimi tells investors in a research note. When combined with Amarin's "position of strength in its expedited appeals argument," the selloff today presents a buying opportunity, contends the analyst. Rahimi sees a low likelihood of an at-risk launch due to the potential liabilities on an appeal loss as well as the complexity of manufacturing. The analyst keeps a Buy rating on Amarin with a $31 price target.Our Take: We think Amarin is already low enough that the risk to reward ratio is in the favor of owning the stock. $AMRN, Amarin Corporation plc / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .Are you interested in trading stocks to supplement your income or make a living? Maybe become a professional trader? Many traders have the skills and nerves to trade, but not the upfront capital. Well now that problem is solved!Try2BeFunded has expanded its trading program! If you're a novice or experienced trader, you can earn access to a trading account with up to $100,000! To learn more about how to qualify, click HERE and give it a shot! You have nothing to lose it is free to try..